Trials / Completed
CompletedNCT01148693
Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting
Comparing Addition of Gentamicin vs. Placebo in Preventing Post ERCP Cholangitis in Non-calculus Stenting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Cholangitis is the most prevalent infectious complication of ERCP. Stenting of biliary strictures and stenosis is one of important risk factors for post-ERCP cholangitis. Adding antibiotics to contrast media has proposed in some studies for prevention of cholangitis but remains controversial. In this study we compare effect of adding gentamicin versus placebo in preventing cholangitis in patients who undergone endoscopic stenting for non-calculus strictures and stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gentamicin | 10mg per 10ml of contrast media |
| DRUG | Placebo | Distilled water |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-06-22
- Last updated
- 2011-09-20
- Results posted
- 2011-08-22
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01148693. Inclusion in this directory is not an endorsement.